/Companies

Curelab Oncology

Dedham, US · Founded 2019 · Delaware corporation

Find your way into Curelab Oncology

25 people in our graph share verified history with the Curelab Oncology team — schools, employers, funds. One of them is your warm intro.

David Sinclairunlockedknows Alexander Shneider · together at Aging (overlapped)
×2knows the team · via Gen3 Partners (at the moment, Invention Machine, Inc.)
×2knows the team · via Boston University School of Public Health
×7knows the team · via Roskilde University

Curelab Oncology develops anti-cancer drugs with a focus on gene therapy and immuno-oncology, taking programs from early discovery through clinical development. It is a biotech company operating in the oncology drug development space.

Founders & leadership

Curelab Oncology was founded in 2019 by Alexander Shneider.

ASAlexander Shneider
Alexander ShneiderFounder & CEO, BoD ChairmanAlexander Shneider is a biotech entrepreneur with over two decades of industry experience in drug development, R&D, and licensing. He holds professor-level positions at international universities and serves on editorial boards for scientific journals.
VGVlad Gabai
Vlad GabaiVP of R&D
CLCharles Legg
Charles LeggCOO
JP
Jason PayneNamed on SEC filing

Board

AMAnatoli Meriin
Anatoli MeriinBoard director

Reported raises · per SEC filings

Form D private placements

$3M disclosed across 1 round · 2022

▶$3MraisedDec 2022 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Charles LeggExecutive Officer
  • Alex ShneiderExecutive Officer
  • Jason PayneExecutive Officer
Offering amount
$3M
Amount sold
$3M
Minimum investment
$10K
Proceeds to insiders
$100K
First sale
Aug 2022
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Curelab Oncology do?
Curelab Oncology develops anti-cancer drugs with a focus on gene therapy and immuno-oncology, taking programs from early discovery through clinical development. It is a biotech company operating in the oncology drug development space.
Who founded Curelab Oncology?
Curelab Oncology was founded by Alexander Shneider in 2019.
How much funding has Curelab Oncology raised?
Curelab Oncology has disclosed $3M raised across 1 round.
Where is Curelab Oncology headquartered?
Curelab Oncology is headquartered in Dedham, US.